O,lead
O,:
O,*
O,3
O,***
O,company
O,reports
O,***
O,3
O,*
O,international
O,clinical
O,labofratories
O,-lrb-
O,otc
O,-rrb-
O,qtr
O,to
O,nov
O,3019861985revenue45
O,,582,00039,608,000
O,net
O,inc247
O,,000739,000
O,share
O,earns
O,.03.10
O,shares
O,outst7
O,,709,0007,381,000
O,*
O,3
O,***
O,company
O,reports
O,***
O,3
O,*
O,international
O,clinical
O,labofratories
O,-lrb-
O,otc
O,-rrb-
O,qtr
O,to
O,nov
O,3019861985revenue45
O,,582,00039,608,000
O,net
O,inc247
O,,000739,000
O,share
O,earns
O,.03.10
O,shares
O,outst7
O,,709,0007,381,000
